SCHEMBL9926

SCHEMBL9926

C[C@@](F)(Oc1ccc(N)cc1)C(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
MAPT P10636 4/20 0.42
MAPK1 P28482 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 1/20 0.42
TDP1 Q9NUW8 6/20 0.41
CYP3A4 P08684 2/20 0.40
TSHR P16473 2/20 0.39
TEAD4 Q15561 1/20 0.38
POLB P06746 1/20 0.36
MAOB P27338 2/20 0.36
TRPV1 Q8NER1 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
MAOA P21397 1/20 0.34
NR4A1 P22736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2029020 0.81 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL29068379 0.80 TRPV1 (0.41) ALDH1A1MAPTMAPK1RAB9ATSHR
Hydrochloric Acid SCHEMBL9586350 0.79 ALDH1A1 (0.43) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL20505766 0.79 ALDH1A1 (0.54) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL12012136 0.79 ALDH1A1 (0.48) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL28331504 0.76 TDP1 (0.39) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL746650 0.75 ALDH1A1 (0.45) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL12012134 0.75 ALDH1A1 (0.45) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL25640383 0.75 ALDH1A1 (0.45) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL21078838 0.74 HSD17B10 (0.61) ALDH1A1MAPK1HPGDTSHRTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed